Realization of the Recommendation for Influenza Vaccination in Pregnant Women
NCT ID: NCT03007797
Last Updated: 2017-01-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
236 participants
OBSERVATIONAL
2012-12-31
2014-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In 2010, the vaccination recommendations for pregnant women against seasonal influenza were published by the German Standing Committee on Vaccination (STIKO). This work deals with the immunization coverage and the influencing factors.
Method:
A cross-sectional study was realized at two Level 1 perinatal centers in two German federal states during the influenza saisons 2012/2013 and 2013/2014. Pregnant women were interviewed by using a standardized and pre-tested questionnaire covering their knowledge about the influenza vaccination and other factors influencing the vaccination decision. Furthermore, data from the vaccination card and the pregnancy record booklet have been evaluated.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Repeated Cross Sectional Surveillance Study To Determine the Influenza Vaccination Rates in German Participants
NCT06800885
Feasibility of Cocooning Immunization Strategy With Influenza Vaccine
NCT00570037
A Study to Describe Pediatric Influenza Vaccine Coverage
NCT00639418
Influenza Vaccine in Pregnant Women
NCT00905125
Influenza Vaccine in Pregnancy Part 2
NCT00593970
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
vaccination rate- pregnant- influenca
vaccination rate for influenza
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
vaccination rate for influenza
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* vaccination records
* signatetd letter of agreement
Exclusion Criteria
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Klinikum Worms
OTHER
University Hospital, Saarland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
homwo 01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.